Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02763124 · ClinicalTrials.gov registry record · NA
Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions
A NA study of Astigmatism, sponsored by Gainesville Eye Associates.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT02763124 is a NA study of Astigmatism that has completed, run by Gainesville Eye Associates. The registered enrollment target is 18 participants, below the 106-participant average among 31 other Astigmatism trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02763124, a NA study of Astigmatism, has completed, sponsored by Gainesville Eye Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess the effectiveness of the Verion-LenSx guided arcuate incision technique to reduce astigmatism in a pseudophakic population.
Conditions Studied
Interventions
- PROCEDURE Verion-LenSx
Study Locations (1)
Georgia
- Gainesville Eye Associates - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02763124
The ClinicalTrials.gov registry entry for NCT02763124 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 106-participant average among 31 other Astigmatism trials with a reported enrollment target (83% lower). The listed sponsor is Gainesville Eye Associates, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Astigmatism appearing as the primary indexed condition, and to 1 intervention - of which Verion-LenSx is the first listed.
NCT02763124 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02763124 about?
NCT02763124 is a clinical study titled "Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions". To assess the effectiveness of the Verion-LenSx guided arcuate incision technique to reduce astigmatism in a pseudophakic population.
What is the current status of trial NCT02763124?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2016-05. Estimated completion is 2016-10.
What conditions does trial NCT02763124 study?
This clinical trial studies the following conditions: Astigmatism.
What interventions are being tested in trial NCT02763124?
The interventions under investigation include: Verion-LenSx (PROCEDURE).
Who is sponsoring clinical trial NCT02763124?
This trial is sponsored by Gainesville Eye Associates, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02763124 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Astigmatism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery
RECRUITING · NA
-
A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism
RECRUITING · NA
-
Contoura With Phorcides Compared to Wavefront Optimized LASIK
RECRUITING · NA
-
Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction
ACTIVE NOT RECRUITING · NA
-
LASIK iDesign vs SMILE
ACTIVE NOT RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.